Role of IRAK1 on TNF-induced proliferation and NF-κB activation in human bone marrow mesenchymal stem cells

Cellular Physiology and Biochemistry

Volumn 30, Issue 1, 2012, Pages 49-60

  Kim, Jong Myung ^a,b   Cho, Hyun Hwa ^a,b   Lee, Sun Young ^a,b   Hong, Chang Pyo ^a,b   Yang, Ji Won ^a,b   Kim, You Sun ^c   Suh, Kuen Tak ^a   Jung, Jin Sup ^a,b,d  

^a Pusan National University School of Medicine   (South Korea)

^b Medical Research Center for Ischemic Tissue Regeneration   (South Korea)

^c Ajou University School of Medicine   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

ERK signaling; hBMSCs; IRAK1; NF B; TNF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

ADULT; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL; CELL PROLIFERATION; DOWN REGULATION; FEMALE; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84863449854     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000339045     Document Type: Article

References (37)

1. Gimble JM, Bunnell BA, Casteilla L, Jung JS, Yoshimura K: Phases I-III Clinical Trials Using Adult Stem Cells. Stem Cells Int 2010:604713.
2. Bruunsgaard H, Pedersen M, Pedersen BK: Aging and proinflammatory cytokines. Curr Opin Hematol 2001;8:31-136.
3. Zhang A, Wang Y, Ye Z, Xie H, Zhou L, Zheng S: Mechanism of TNF- A-induced migration and hepatocyte growth factor production in human mesenchymal stem cells. J Cell Biochem 2010:111:469-475.
4. Abshagen K, Eipel C, Kalff JC, Menger MD, Vollmar B: Loss of NF-KB activation in Kupffer cell-depleted mice impairs liver regeneration after partial hepatectomy Am J Physiol Gastrointest Liver Physiol 2007;292: G1570-G1577. (Pubitemid 47080610)
5. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006;291:R880-R884. (Pubitemid 44498426)
6. Wang Y, Weil BR, Herrmann JL, Abarbanell AM, Tan J , Markel TA, Kelly ML, Meldrum DR: MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells. Am J Physiol Cell Physiol 2009;297:C1284-C1293.
7. Kim YS, Park H J , Hong MH, Kang PM, Morgan JP, Jeong MH, Cho JG, Park JC, Ahn Y: TNF-a enhances engraftment of mesenchymal stem cells into infarcted myocardium. FrontBiosci 2009;14:2845-2856.
8. Tan J , Weil BR, Abarbanell AM, Wang Y, Herrmann JL, Dake ML, Meldrum DR: Ablation of TNF-a receptors influences mesenchymal stem cell-mediated cardiac protection against ischemia. Shock 2010;34:236-242.
9. Xu H, Sethi JK, Hotamisligil GS: Transmembrane tumor necrosis factor (TNF)-a inhibits adipocyte differentiation by selectively activating TNF receptor 1. J Biol Chem 1999;274:26287-26295.
10. Filipak M, Sparks RL, Tzen CY, Scott RE: Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation. J Cell Physiol 1988;137:367-373. (Pubitemid 19009036)
11. Cho HH, Shin KK, Kim YJ, Song JS, Kim JM, Bae YC, Kim CD, Jung JS: NF-KB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 2010;223:168-177.
12. Bocker W, Docheva D, Prall WC, Egea V, Pappou E, Rossmann 0, Popov C, Mutschler W, Ries C, Schieker M: IKK-2 is required for TNF- A-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med (Berl) 2008;86:1183-1192.
13. Ghali 0, Chauveau C, Hardouin P, Broux 0, Devedjian JC: TNF-alpha's effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression. J Bone Miner Res 2010;25:1616-1626.
14. Jiang Y, Woronicz JD, Liu W, Goeddel DV: Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 1999;283:543-546.
15. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-KB activation. Cell 1995;81:495-504.
16. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996;4:387-396. (Pubitemid 26174054)
17. Hsu H, Shu HB, Pan MG, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84:299-308. (Pubitemid 26042835)
18. Shu HB, Takeuchi M, Goeddel DV: The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 1996;93:13973-13978.
19. Lee TH, Huang Q, Oikemus S, Shank J , Ventura J J , Cusson N, Vaillancourt RR, Su B, Davis R J , Kelliher MA: The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase. Mol Cell Biol 2003;23:8377-8385. (Pubitemid 37377526)
20. Winston BW, Lange-Carter CA, Gardner AM, Johnson GL, Riches DW: Tumor necrosis factor alpha rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages. Proc Natl Acad Sci USA 1995;92:1614-1618.
21. Schievella AR, Chen JH, Graham JR, Lin LL: MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J Biol Chem 1997;272:12069-12075. (Pubitemid 27202786)
22. Gottipati S, Rao NL, Fung-Leung WP: IRAKI: a critical signaling mediator of innate immunity. Cell Signal 2008;20:269-276.
23. Vig E, Green M, Liu Y, Donner DB, Mukaida N, Goebl MG, Harrington MA: Modulation of tumor necrosis factor and interleukin-1-dependent NF-KB activity by mPLK/IRAK. J Biol Chem 1999;274:13077-13084.
24. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS: Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-324. (Pubitemid 39179200)
25. Li H, Lin X: Positive and negative signaling components involved in TNFa-induced NF-KB activation. Cytokine 2008;41:1-8. (Pubitemid 50012147)
26. Yamamoto K, Arakawa T, Ueda N, Yamamoto S: Transcriptional roles of nuclear factor KB and nuclear factor-interleukin-6 in the tumor necrosis factor a-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Cheml995; 270:31315-31320.
27. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L: IL-lbeta-mediated up-regulation of HIF-la via an NF-KB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003;17:2115-2117.
28. Yin Y, Wang S, Sun Y, Matt Y, Colburn NH, Shu Y, Han X: JNK/AP-1 pathway is involved in tumor necrosis factor-a induced expression of vascular endothelial growth factor in MCF7 cells. Biomed Pharmacother 2009;63:429-435.
29. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J 1995;9:726-735.
30. Liu ZG, Han J: Cellular responses to tumor necrosis factor. Curr Issues Mol Biol 2001;3:79-90. (Pubitemid 33061771)
31. Kwon HJ, Breese EH, Vig-Varga E, Luo Y, Lee Y, Goebl MG, Harrington MA: Tumor necrosis factor a induction of NF-KB requires the novel coactivator SIMPL. Mol Cell Biol 2004;24:9317-9326. (Pubitemid 39391670)
32. Luo Y, Kwon HJ, Montano S, Georgiadis M, Goebl MG, Harrington MA: Phosphorylation of SIMPL modulates RelA-associated NF-KB-dependent transcription. Am J Physiol Cell Physiol 2007;292:C1013-1023. (Pubitemid 46440405)
33. Thomas JA, Allen JL, Tsen M, Dubnicoff T, Danao J, Liao XC, Cao Z, Wasserman SA: Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J Immunol 1999;163:978-984. (Pubitemid 29328110)
34. Thomas JA, Haudek SB, Koroglu T, Tsen MF, Bryant DD, White DJ, Kusewitt DF, Horton JW, Giroir BP: IRAKI deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction. Am J Physiol Heart Circ Physiol 2003;285:H597-606. (Pubitemid 36885890)
35. Chen ZJ: Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 2005;7:758-765.
36. Vig E, Green M, Liu Y, Yu KY, Kwon HJ, Tian J, Goebl MG, Harrington MA: SIMPL is a tumor necrosis factor-specific regulator of nuclear factor-KB activity. J Biol Chem 2001;276:7859-7866.
37. Benson EA, Goebl MG, Yang FC, Kapur R, McClintick J, Sanghani S, Clapp DW, Harrington MA: Loss of SIMPL compromises TNF- A-dependent survival of hematopoietic progenitors. Exp Hematol 2010;38:71-81.